ArticleBreast cancer research : BCR2020

Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer.

Athina Giannoudis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.